Books by Larry Hobbs available on Amazon
QUOTE OF THE DAY
QUICKLINKS AND VIEW OPITONS
Wednesday, July 08, 2020
HYDROXYCHLOROQUINE | COVID-19
How many lives could have been saved if the U.S. would have used hydroxychloroquine for Covid-19?
How many lives could have been saved if the U.S. would have used hydroxychloroquine, with or without azithromycin and zinc, to treat Covid-19?
4,076 people had died from Covid-19 in the US as of April 1, 2020 when infectious disease specialist Stephen Smith, MD said, “It’s a game changer [referring to using hydroxychloroquine plus azithromycin]. This is the beginning of the end of the pandemic.”
On July 7, 2020, 133,644 people in the U.S. had died from Covid-19.Read the entire article | Email this article
Sunday, July 05, 2020
Dr. O’Neill prescribed hydroxychloroquine to numerous COVID patients, saw improvement in all o
“Dr. [William] O’Neill says he has prescribed hydroxychloroquine to help numerous coronavirus patients, and saw improvement in all of them,” Sharyl Attkisson noted on her television show, Full Measure.
William O’Neill, MD is a cardiologist and medical director at the Henry Ford Health System which has six (6) hospitals in Detroit, Michigan.
Dr. O’Neill was one of the coauthors of the study (article posted here) which analyzed 2,541 COVID-19 patients hospitalized between March 10, 2020 and May 2, 2020 across Henry Ford Health System’s six (6) hospitals, and found that patients given hydroxychloroquine alone were 66% less likely to die than patients who were not given the drug; those given hydroxychloroquine plus azithromycin were 71% less likely to die.Read the entire article | Email this article
Saturday, July 04, 2020
Hydroxychloroquine use was associated with a 47% decreased risk of in-hospital mortality
Hydroxychloroquine use was associated with a 47% decreased risk of in-hospital mortality according to an analysis of data from 6493 patients who had laboratory-confirmed COVID-19 with clinical outcomes between March 13 and April 17, 2020, who were seen in one of the Mount Sinai Health System’s eight (8) hospitals and/or over 400 ambulatory practices in the New York City metropolitan area.Read the entire article | Email this article
Friday, July 03, 2020
Hydroxychloroquine, 66% lower risk of death from Covid-19, Henry Ford Health
An analysis of 2,541 COVID-19 patients hospitalized between March 10, 2020 and May 2, 2020 across Henry Ford Health System’s six (6) hospitals found that patients given hydroxychloroquine alone were 66% less likely to die than patients who were not given the drug, and those given hydroxychloroquine plus azithromycin were 71% less likely to die.
None of the patients given hydroxychloroquine, with or without azithromycin, developed heart arrhythmias.
Among a subset of 380 COVID-19 patients (190 + 190) who were matched for age, gender, race, etc., those given hydroxychloroquine alone were 51% less likely to die than matched patients who were not given the drug.Read the entire article | Email this article
Thursday, June 25, 2020
Hydroxychloroquine helps stop progression of Covid-19 says U.S. Secretary of Veterans Affairs
Monday, June 22, 2020
Morocco uses hydroxychloroquine, has death rate per capita 62-times lower than that of the U.S.
Morocco, with a population of 36 million, has only had 214 deaths from Covid-19 as of June 22, 2020.
Morocco’s death rate per capita from Covid-19 is 40-times lower than that of Europe and 62-times lower than that of the U.S.
Jaouad Zemmouri, a Moroccan scientist, believes that this is because Morocco uses hydroxychloroquine as noted in an article published on Morocco World News on June 22, 2020.
If the U.S. had Morocco’s death rate based on population size, only 1,968 people would have died in the U.S. from Covid-19 as of June 22, 2020 rather than 122,610.
Read the entire article | Email this article
Thursday, June 18, 2020
People died of Covid-19 because the FDA restricted the use of hydroxychloroquine, Stephen Smith, MD
People died of Covid-19 because the FDA restricted hydroxychloroquine according to Stephen Smith, MD, an infectious disease specialist from New Jersey.
Dr. Smith notes that the 2400 mg cumulative dose [over 5 days] that the FDA had recommended is a “ridiculously low dose”.
He says that “even the 6,000 mg [cumulative] dose over 10 days is still not a large dose.”
He says, “I don’t know how [FDA Commissioner Stephen Hahn, MD] could have botched this any worse.”Read the entire article | Email this article
FDA should not have restricted the use of hydroxychloroquine for Covid-19 patients, Ramin Oskoui, MD
The FDA should not have restricted the use of hydroxychloroquine for Covid-19 patients, Ramin Oskoui MD says in this 37-second video clip.
He also says that some hospitals do not want to use it because researchers at these hospitals are getting grant money from other drug companies.Read the entire article | Email this article
Wednesday, June 17, 2020
Hydroxychloroquine may now be prescribed by any doctor to any patient for any reason
Hydroxychloroquine may now be prescribed by any doctor to any patient for any reason including to prevent or treat Covid-19 according to Alex Azar, Secretary of Health and Human Services, following the FDA’s June 15, 2020 removal of the Emergency Use Authorization for hydroxychloroquine.Read the entire article | Email this article
Friday, June 05, 2020
Lancet hydroxychloroquine Covid19 study was a lie
A study published in The Lancet claimed that chloroquine and hydroxychloroquine increases the risk of death in COVID-19 patients.
But the data used in this study appear to have been “completely fabricated”, “in what is possibly a criminal conspiracy” according to Peter Ellis, a professional statistician and data scientist.
The Lancet paper was retracted on June 5, 2020, and the world Health Organization resumed trials of hydroxychloroquine for treating Covid-19, which had been stopped due to this “study”.Read the entire article | Email this article
Monday, May 18, 2020
HYDROXYCHLOROQUINE | COVID-19
William O’Neill MD has given hydroxychloroquine to COVID-19 patients, saw improvement in all of them
William O’Neill, MD, a cardiologist and a medical director at Henry Ford Health System in Detroit, Michigan, has given hydroxychloroquine to help numerous COVID-19 patient and saw improvement in all of them as noted in an interview by Sharyl Attkisson on the TV show Full Measure which aired on May 17, 2020.Read the entire article | Email this article
HYDROXYCHLOROQUINE | COVID-19
Hydroxychloroquine given to 400 COVID-19 patients with no adverse effects,
William O’Neill, MD, a cardiologist and a medical director at Henry Ford Health System in Detroit, Michigan, says that he as well as his colleagues at the University of Washington—I am going to guess that he meant to say Washington University, which is in St. Louis, Missouri—and the University of Minnesota have given hydroxychloroquine to help 400 COVID-19 patients, and they have not seen any adverse effects as noted in an interview by Sharyl Attkisson on the TV show Full Measure which aired on May 17, 2020.Read the entire article | Email this article
Saturday, May 16, 2020
Dr. Ivette Lozano using hydroxychloroquine for Covid-19 patients
Here is a one-minute video clip of Ivette Lozano, MD from Dallas, Texas talking about her experience with giving hydroxychloroquine to Covid-19 patients.
She talks about how pharmacists are giving her a hard time about prescriptions for hydroxychloroquine, and even refusing to fill the prescriptions, and that people are coming from all over Texas because their doctors are afraid to prescribe hydroxychloroquine for fear of getting in trouble with the licensing board.Read the entire article | Email this article
Wednesday, May 06, 2020
HYDROXYCHLOROQUINE FOR COVID-19
Hydroxychloroquine decreased mortality in critically-ill COVID-19 patients (19% vs 46%)
Among 568 critically-ill patients treated in a similar manner, 45.8% of those not given hydroxychloroquine died (238/520) versus 18.8% of those given hydroxychloroquine (9/48) — 200 mg twice a day for 7-10 days — according to a retrospective study from China.Read the entire article | Email this article
Thursday, April 30, 2020
COVID-19 AND HYDROXYCHLOROQUINE
Why I do not believe the Veterans Administration (VA) hydroxychloroquine study
I do not believe the Veterans Administration (VA) hydroxychloroquine study which seems to suggest that they drug increases the risk of death in Covid-19 patients.
They only reported on 70 deaths through April 11, 2020, but a graph on Stars & Stripes website shows that there were roughly 210 people who had died of this date.
It appears that the VA study left out two-thirds of the data.Read the entire article | Email this article
Friday, April 03, 2020
Covid-19: Evidence hydroxychloroquine may be effective for preventing Covid-19 comes from Africa
Tuesday, March 31, 2020
Wall St Journal, Hydroxychloroquine Use in Coronavirus Patients
Here are highlights from an article in the Wall Street Journal written by two doctors for using hydroxychloroquine plus azithromycin for treating people with Covid-19.
“Use this treatment cocktail early, and don’t wait until a patient is on a ventilator in the intensive-care unit.”Read the entire article | Email this article
Wednesday, March 18, 2020
Hydroxychloroquine + azithromycin eliminated COVID-19 virus in 95% of patients in 6 days
Hydroxychloroquine (200 mg three times a day) eliminated the coronavirus COVID-19 in 75% of patients after 6 days, while hydroxychloroquine plus the antibiotic azithromycin (500 mg on day 1 followed by 250 mg per day for the next four days) eliminated the virus in 95% of patients after 6 days according to a study done by French biologist and Infectious Disease Specialist, Prof. Didier Raoult, MD, PhD as noted in an article on Medscape.Read the entire article | Email this article
Monday, March 16, 2020
It would be a medical mistake not to give hydroxychloroquine for COVID-19 notes Prof. Didier Raoult
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.